Drug Database
Back to search

United States· US:55513-956_be266b46-ea99-47f5-b6c2-a2f8afc863c6

Vectibix

A panitumumab product containing panitumumab, registered in United States by Amgen, Inc. The same ATC class is registered in 13 of our 19 countries.

ATC L01FE02US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedVectibixATCL01FE02REGISTER NO.US:55513-956_be266b46…PACKS LISTED2CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about panitumumabAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Panitumumab is registered in 13 of 19 countries.

Countries holding a registration under ATC L01FE02 (panitumumab), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 8 of them publish a price we can compare per daily dose
Search panitumumab products by name

Panitumumab · ATC L01FE02

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
panitumumab
Manufacturer
Amgen, Inc
Country
United States (US)
ATC code
L01FE02
ATC class
Panitumumab
Defined daily dose
30 mg, P
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 2

  • ndc11
    5551395601
    1 VIAL, SINGLE-DOSE in 1 CARTON (55513-956-01) / 20 mL in 1 VIAL, SINGLE-DOSE
  • ndc11
    5551395621
    1 VIAL, SINGLE-DOSE in 1 CARTON (55513-956-21) / 20 mL in 1 VIAL, SINGLE-DOSE

Regulatory notes

UNII (FDA substance ID)
6A901E312A
PANITUMUMAB
RxCUI 263034
DailyMed SPL labels
1 version tracked

Interactions

27 interactions on record for panitumumab.

Graded by severity as the source publishes them — 14 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check panitumumab against other medicinesHow interaction checks work

Panitumumab · interactions on record

27 records

  • 14 severe
  • 13 moderate

Most severe, free to view

  • AmiodaroneC01BD01severe
  • DofetilideC01BD04severe
  • DronedaroneC01BD07severe
  • IrinotecanL01CE02severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Panitumumab in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All panitumumab products

Authorised across Europe · EMA

The same active substance is authorised in 2 EEA countries. Names it is sold under:

  • Iceland · Vectibix
  • Norway · Vectibix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/3feb5ee5-ac6a-430a-a6fe-73453ed95ba7
GET /v1/drugs/3feb5ee5-ac6a-430a-a6fe-73453ed95ba7?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "6A901E312A",
    "rxcui": "263034",
    "inchikey": null,
    "display_name": "PANITUMUMAB",
    "substance_type": "protein",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "INTRAVENOUS",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 5
  },
  "spl_meta": {
    "e0fa4bca-f245-4d92-ae29-b0c630a315c2": {
      "match": "brand_token",
      "title": "VECTIBIX (PANITUMUMAB) SOLUTION [AMGEN, INC]",
      "spl_version": "160",
      "published_date": "2026-03-18"
    }
  },
  "productid": "55513-956_be266b46-ea99-47f5-b6c2-a2f8afc863c6",
  "productndc": "55513-956",
  "dosage_form": "SOLUTION",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "PANITUMUMAB",
  "proprietary_name": "Vectibix",
  "active_ingred_unit": "mg/20mL",
  "application_number": "BLA125147",
  "marketing_category": "BLA",
  "nonproprietary_name": "panitumumab",
  "start_marketing_date": "20061010",
  "active_numerator_strength": "400"
}
API referenceMCP serverPlans

See everything about panitumumab.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console